AzTrials
AzTrials

Chest TraumaNCT06264856

Bronchoscopy for Thoracic Trauma Patients

A study testing bronchoscopic sputum suction and negative pressure aspiration suction in people with Chest Trauma, run by National Taiwan University Hospital at 2 sites in Taiwan.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The study aims to evaluate the effectiveness of bronchoscopic sputum suction in patients with severe thoracic illness-induced respiratory failure. The study will compare the outcomes of patients who receive bronchoscopic sputum suction versus blind negative pressure aspiration for sputum removal. Read more about this study

Who is it for?
Ages 20 to 99 years
Conditions the study is for
Chest Trauma
What is being tested?
bronchoscopic sputum suction and negative pressure aspiration suction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesTaiwan
Study dates
1 Dec 2024to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants must be 20 years of age or older.
  • Participants of all genders are eligible.
  • Participants who are not in good health are not eligible.
  • Participants with an Injury Severity Score greater than 9 and who have chest trauma are eligible.

Who cannot join

  • Patients with traumatic brain injury.
  • Patients with active pulmonary tuberculosis or other respiratory diseases with suspected contagion.
  • Patients with poor blood clotting function or a tendency to bleed.
  • Patients with aortic aneurysm. Patients with unstable vital signs or those who cannot maintain oxygen saturation above 90% while performing the test with Fraction of Inspired Oxygen (FiO2) greater than 80% or on 100% oxygen.
  • Immunocompromised patients.
  • Patients with acute massive hemoptysis.
Show all 9Show fewer
  • Patients with pre-existing neuromuscular diseases or those at high risk for arrhythmias, myocardial ischemia, or pulmonary embolism.
  • Patients who are unable to clearly express their willingness to sign the informed consent form.
  • Patients who have frequent intermittent sputum suction or are unable to fast for 4 hours due to their medical condition.

Trial locations and contacts

2 sites in 1 country.

Taiwan2 sites
  • Department of Traumatology, National Taiwain University Hospital

    Taipei, 10002

  • NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch

    Taipei, 100; 300; 640; 280

Other trials in Taiwan

About this study

Official title: Flexible-bronchoscopy Trial for Moderate and Severe Thoracic Trauma Patients Without Brain Injury

The study aims to evaluate the effectiveness of bronchoscopic sputum suction in patients with severe thoracic illness-induced respiratory failure. The study will compare the outcomes of patients who receive bronchoscopic sputum suction versus blind negative pressure aspiration for sputum removal. The study will measure baseline data, postoperative blood gas conditions, and clinical parameters, such as time of invasive ventilation, total time of ventilation, hospital stay, weaning success rate, reintubation rate, ventilator-associated pneumonia incidence, and fatality rate. The study aims to determine whether bronchoscopy-assisted sputum removal is superior to blind negative pressure aspiration in improving patient outcomes.

Read the detailed description

The aim of the present randomized control trial is to assess the value of bronchoscopic sputum suction in patients with severe thoracic illness-induced respiratory failure. To decrease group differences in baseline characteristics and blood gas conditions, patients will be randomly assigned to receive either bronchoscopy-assisted or negative pressure aspiration for sputum suction, while the remaining treatment course will be the same. The study will measure major clinical indicators such as time of invasive ventilation, total time of ventilation, hospital stay, weaning success rate, reintubation rate, ventilator-associated pneumonia incidence, and fatality rate to provide strong evidence for the efficacy of each suction method.

Conditions
Chest Trauma
Being tested
bronchoscopic sputum suction, negative pressure aspiration suction
Medical subject headings
Thoracic Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bronchoscopic sputum suctionProcedure or surgery

    Bronchoscopy is a medical procedure in which a flexible tube called a bronchoscope is passed through the mouth or nose and into the lungs. Bronchoscopic suction is a technique used during bronchoscopy to remove secretions, mucus, or foreign objects from the airways.

    The bronchoscope is equipped with a suction port and a suction channel that allows the doctor to remove fluids or other material from the airways. The suction port is connected to a vacuum source, and the suction channel runs through the bronchoscope and terminates at the tip of the instrument.

  • negative pressure aspiration suctionProcedure or surgery

    The procedure involves inserting a catheter into the airway and applying negative pressure to the catheter to suction out the secretions or fluids. The patient could receive sputum suction as medical routine (every 2-4 hrs) if needed.

Study groups in NCT06264856
Study groupRoleWhat they receive
bronchoscopic suctionExperimentalBronchoscopic suction is a medical procedure used to remove excess mucus, secretions, and foreign objects from the airways through a bronchoscope. The patient would receive bronchoscopic sputum suction every 24-48 hrs after randomization until leaving ICU.. The patient could still receive blind negative pressure aspiration suction as the usual medical routine(every 2-4 hrs sputum suction if needed).
Receives: Procedure: bronchoscopic sputum suction
blind negative pressure aspiration suctionActive comparatorNegative pressure aspiration suction is a medical procedure that uses suction to remove fluids, mucus, or other materials from the body by creating a negative pressure or vacuum. The procedure involves inserting a catheter into the airway and applying negative pressure to the catheter to suction out the secretions or fluids. The patient would receive blind negative pressure aspiration suction as the usual medical routine(every 2-4 hrs sputum suction if needed).
Receives: Procedure: negative pressure aspiration suction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of pneumonia

    diagnosis of pneumonia was determined according to radiologic evidence of new or progressive infiltrate of more than 48 hours and laboratory detection of a causative agent.

    The management and diagnosis of all patients was performed by a trauma specialist.

    Measured: 30 days after randomization

Secondary outcomes (4)
  1. Intensive Care Unit admission interval

    measure the time of total Intensive Care Unit admission interval

    Measured: 30 days

  2. admission interval

    measure the time of total admission interval

    Measured: up to 24 weeks (from randomization to discharge)

  3. tracheostomy rate

    measure the rate of patient who receive tracheostomy in this admission

    Measured: up to 24 weeks (from randomization to discharge)

  4. intubation rate

    measure the rate of intubation rate

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2024
  2. Study start1 Dec 2024 (estimated)
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Why it stopped: The principal investigator will be studying abroad for one year. The study is expected to resume enrollment from December 1, 2024.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06264856
Sponsor's protocol ID
202210096RIND
Status last verified
Apr 2023
First submitted
3 Apr 2023
Last updated
20 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing bronchoscopic sputum suction and negative pressure aspiration suction in people with Chest Trauma, run by National Taiwan University Hospital at 2 sites in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of pneumonia (time frame: 30 days after randomization). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in